Quadrupole-Orbitrap Hybrid Mass Spectrometer

The Food and Drug Administration (FDA) is seeking to purchase a Quadrupole-Orbitrap Hybrid Mass Spectrometer for qualitative and quantitative proteomic research methods. The instrument must meet specific technical specifications, including an acquisition speed of 70 Hz, sensitivity of less than 1.5 fg, mass accuracy of less than 1 ppm, and resolving power of 480,000 FWHM at m/z 200. The contractor shall deliver and install the instrument at the FDA location in College Park, Maryland, and provide a one-year service contract, instructor-led on-site training, and other requirements. Key points to consider: • The acquisition is set aside for small business concerns. • The instrument must be newly manufactured and meet the specified technical requirements. • The contractor must provide a one-year warranty and service contract. • The contractor must deliver and install the instrument at the FDA location in College Park, Maryland. • The contractor must provide instructor-led on-site training at the FDA location.